A detailed history of Alliancebernstein L.P. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Alliancebernstein L.P. holds 199,259 shares of URGN stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,259
Previous 23,400 751.53%
Holding current value
$1.85 Million
Previous $297,000 614.48%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$10.52 - $13.11 $1.85 Million - $2.31 Million
175,859 Added 751.53%
199,259 $2.12 Million
Q3 2024

Nov 14, 2024

SELL
$12.7 - $17.92 $137,541 - $194,073
-10,830 Reduced 31.64%
23,400 $297,000
Q2 2024

Aug 14, 2024

BUY
$12.72 - $19.2 $435,405 - $657,216
34,230 New
34,230 $574,000
Q2 2022

Aug 15, 2022

SELL
$5.12 - $8.74 $125,440 - $214,130
-24,500 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$15.2 - $20.94 $39,520 - $54,444
2,600 Added 11.87%
24,500 $374,000
Q2 2019

Aug 14, 2019

BUY
$32.75 - $40.35 $717,225 - $883,665
21,900 New
21,900 $787,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $211M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.